Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
Patients with LE and are taking hydroxychloroquine:N/A
Patients with LE and are not taking hydroxychloroquine:N/A
Patients with dermatomyositis and are taking hydroxychloroquine:N/A
Patients with dermatomyositis and are not taking hydroxychloroquine:N/A
Patients with RA and are taking hydroxychloroquine:N/A
Patients with RA and are not taking hydroxychloroquine:N/A
Patients with rosacea and are taking hydroxychloroquine:N/A
Patients with rosacea and are not taking hydroxychloroquine:N/A
Sponsors
The 2nd Xiangya Hospital of Central South Uinvercity
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients with clinically confirmed rosacea and certain autoimmune?diseases (such as LE, dermatomyositis, RA, Sjogren syndrome or UCTD); 2. Have exposure to people with SARS-CoV-2 infection or diagnosed as COVID-19; Or, living in the epidemic regions of SARS-CoV-2; Or, have ever gone to the epidemic regions; Or, have ever contacted with people from the epidemic regions.
Exclusion criteria
Exclusion criteria: The patient himself/herself cannot finish the survey, while no caregiver who is familiar with patients condition is available.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of SARS-CoV-2 infection (including confirmed SARS-CoV-2 detection, but might asymptomatic);Incidence of COVID-19 pneumonia; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of Symptoms Compatible with COVID19 (possible disease, could recover without doctor intervention); | — |
Countries
China
Contacts
Public ContactQianjin Lu
The Second Xiangya Hospital of Central South University
Outcome results
None listed